ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The protoapigenone analog WYC0209 targets CD133+cells: A potential adjuvant agent against cancer stem cells in urothelial cancer therapy

Yeh, Bi-Wen; Yu, Liang-En; Li, Ching-Chia; Yang, Juan-Cheng; Li, Wei-Ming; Wu, Yang-Chang; Wei, Yu-Ching; Lee, Hsueh-Te; Kung, Mei-Lang; Wu, Wen-Jeng河北医科大学; 中山大学
Toxicology and Applied Pharmacology2020-9-1DOI: 10.1016/j.taap.2020.115129
6阅读
引用收藏
分享

摘要

Urothelial carcinoma (UC) is one of the highest incidence cancers that rank the fourth commonly diagnosed tumors worldwide. The unresectable lesions that are resistant to therapeutic interventions is the major cause leading to death. Previous studies had shown that the resistance and metastatic consequence may arise from cancer stem-like cells population. The phytochemical flavonoids have promised bioactivity and potent anti-carcinogenic effects, and trap great attentions for cancer chemoprevention and/or adjuvant chemotherapy. However, the mechanisms of flavonoids on cancer stemness is still obscured. In this study, we analyzed the biofunctional effects of as-prepared flavonoid derivative-WYC0209 on T24, BFTC905 and BFTC909 human UC cell lines. Our results demonstrated that WYC0209 significantly induced anti-cell viability on UC cells through decreased Akt/NEkB signaling. Moreover, WYC0209 enhanced the cell apoptosis through activated the caspase-3 activity and inactivated Bcl-xL expression. Interestingly, WYC0209 dramatically inhibited the cancer stem cells (CSCs) traits, including attenuation of side population and tumorsphere formation in which were through declined EMT-CSCs markers including MDR1, ABCG2 and BMI-1. We further validated the effects of WYC0209 on several CSC surface markers including CD133, CD44, SOX-2 and Nanog. Our results showed that WYC0209 markedly inhibited CD133 expressions in both transcriptional and translational levels. High expression levels of CD133 was also demonstrated in human upper tract UC specimens. In summary, our study showed that WYC0209 may potentially as an adjuvant agent to against CD133-driven UC CSCs and provide a beneficial strategy to against UC cancer therapeutics resistant.

学科与关键词

关键词
WYC0209Urothelial carcinomaCancer sternness cellsChemoresistanceCD133
相关
加载中…
  • Properties of flavonoids in the treatment of bladder cancer (Review)
    Lv, Yue; Liu, Zhonghao; Jia, Haixing; Xiu, Youcheng; Liu, Zan; Deng, LeihongExperimental and Therapeutic Medicine, 2022, 24(5): 676.被引 5
  • Stem cells in the biology of normal urothelium and urothelial carcinoma
    J. HATINA; W. A. SCHULZNeoplasma, 2012, 59(06): 728-736.
  • c-Myc Acts as a Competing Endogenous RNA to Sponge miR-34a, in the Upregulation of CD44, in Urothelial Carcinoma.
    Chen, Pie-Che*; Yu, Chih-Chia*; Huang, Wen-Yu; Huang, Wan-Hong*; Chuang, Yu-Ming*; Lin, Ru-Inn*; Lin, Jora M J*; Lin, Hon-Yi*; Jou, Yeong-Chin*; Shen, Cheng-Huang*; Chan, Michael W Y*Cancers (Basel), 2019, 11(10).
查看全部 →

发表信息

论文状态
公开发表
期刊
Toxicology and Applied Pharmacology
发表日期
2020-09-01
卷期
第 402 卷
页码
115129
DOI
10.1016/j.taap.2020.115129
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
2区
成果收录
SCIE
资助标注
Ministry of Science and Technology of TaiwanMinistry of Science and Technology, Taiwan [MOST 104-2314-B-037-050-MY3, MOST107-2314-B-037-077-MY3]; Kaohsiung Medical University Hospital [KMUH107-7R59]; Kaohsiung Medical University [KMU-KI109002]; Regenerative Medicine and Cell Therapy Research Center Grant [KMU-TC108A02]; Cohort Research Center [KMU-TC108B07]; MOST [106-2321-B-075B-002-MY3]; Kaohsiung Veterans General Hospital [VGHKS109-177]

作者

  • Y

    Yeh, Bi-Wen (第一作者)

  • Y

    Yu, Liang-En

查看全部 10 位作者收起作者
  • L

    Li, Ching-Chia

  • Y

    Yang, Juan-Cheng

  • L

    Li, Wei-Ming

  • W

    Wu, Yang-Chang

  • W

    Wei, Yu-Ching

  • L

    Lee, Hsueh-Te

  • K

    Kung, Mei-Lang

  • W

    Wu, Wen-Jeng

    inst med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417